Botox

OnabotulinumtoxinA for Tension-Type Headache: Research vs Real-Life Settings

OnabotulinumtoxinA for Tension-Type Headache: Research vs Real-Life Settings

By

Despite its prevalence, tension-type headache is often complicated by overlapping symptoms and a weak understanding of tension-type headache etiology.

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

By

OnabotulinumtoxinA was shown to have a better outcome in patients with chronic migraine who start the treatment within 12 months of symptom onset.

OnabotulinumtoxinA Injections Reduce Chronic Migraine in Pediatric Patients

OnabotulinumtoxinA Injections Reduce Chronic Migraine in Pediatric Patients

By

Frequent onabotulinumtoxinA injections during a 5-year period provide effective analgesic benefits in pediatric patients presenting with chronic migraine.

Onabotulinumtoxin A for Migraine: High Satisfaction, Compliance

Onabotulinumtoxin A for Migraine: High Satisfaction, Compliance

By

Most centers follow recommended guidelines for the use of onabotulinumtoxin A in chronic migraine and applied a consistent measure of response to therapy of a 30% to 50% reduction in headache days.

Botox for Pediatric Refractory Migraine?

Botox for Pediatric Refractory Migraine?

By

Botox treatment led to significant improvement in the intensity and frequency of migraine.

Sign Up for Free e-Newsletters